78 related articles for article (PubMed ID: 3791273)
1. Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial.
Moore MR; Graham SD; Birch R; Irwin L
Cancer Treat Rep; 1987 Jan; 71(1):89-90. PubMed ID: 3791273
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of weekly cisplatin in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group Trial.
Moore MR; Troner MB; DeSimone P; Birch R; Irwin L
Cancer Treat Rep; 1986 Apr; 70(4):541-2. PubMed ID: 3698053
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
[No Abstract] [Full Text] [Related]
4. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
[No Abstract] [Full Text] [Related]
5. Phase II trial of mitoguazone in patients with refractory germ cell tumors.
Chun H; Bosl GJ
Cancer Treat Rep; 1985 Apr; 69(4):461-2. PubMed ID: 2986835
[No Abstract] [Full Text] [Related]
6. Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.
Inamasu MS; Oishi N; Chen TT; Kraut EH; Grozea PN; Costanzi JJ; Bonnet JD
Cancer Treat Rep; 1986 Apr; 70(4):531-2. PubMed ID: 3698049
[No Abstract] [Full Text] [Related]
7. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
Thongprasert S; Bosl GJ; Geller NL; Wittes RE
Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
[No Abstract] [Full Text] [Related]
8. Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group.
Knight WA; Loesch DM; Leichman LP; Fabian C; O'Bryan RM
Cancer Treat Rep; 1982 Dec; 66(12):2099-100. PubMed ID: 7139653
[No Abstract] [Full Text] [Related]
9. Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.
Debruyne FM; Karthaus HF; Schröder FH; de Voogt HJ; de Jong FH; Klijn JG
Prog Clin Biol Res; 1985; 185A():251-70. PubMed ID: 3929265
[No Abstract] [Full Text] [Related]
10. Methylglyoxal-bis(guanylhydrazone) in hormone-resistant adenocarcinoma of the prostate.
Scher HI; Yagoda A; Ahmed T; Watson RC
J Clin Oncol; 1985 Feb; 3(2):224-8. PubMed ID: 3968552
[TBL] [Abstract][Full Text] [Related]
11. Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
Knight WA; Drelichman A; Fabian C; Bukowski RM
Cancer Treat Rep; 1983 Dec; 67(12):1139-40. PubMed ID: 6652631
[No Abstract] [Full Text] [Related]
12. Phase II study of spirogermanium in metastatic prostate cancer.
Dexeus FH; Logothetis C; Samuels ML; Hossan B
Cancer Treat Rep; 1986 Sep; 70(9):1129-30. PubMed ID: 3742495
[No Abstract] [Full Text] [Related]
13. Phase II trial of methyl-GAG in advanced renal cancer.
Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
[No Abstract] [Full Text] [Related]
14. Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
Yap HY; Blumenschein GR; Schell F; Bodey GP
Cancer Treat Rep; 1981; 65(5-6):465-7. PubMed ID: 7237467
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of mitoguazone in children with leukemia and lymphoma: a Pediatric Oncology Group Study.
Kinney TR; Krischer JP; Starling KA; Alvarado C; Kamen B
Cancer Treat Rep; 1986 Aug; 70(8):1041-2. PubMed ID: 3524835
[No Abstract] [Full Text] [Related]
16. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
[No Abstract] [Full Text] [Related]
17. Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
Fuks JZ; Van Echo DA; Aisner J; Mitchell EP; Woolley PV; Wiernik PH
Cancer Clin Trials; 1981; 4(4):411-4. PubMed ID: 7318123
[TBL] [Abstract][Full Text] [Related]
18. European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer.
Jones WG; Fosså SD; Bono AV; Klijn JG; De Pauw M; Sylvester R
Cancer Treat Rep; 1987 Dec; 71(12):1317-8. PubMed ID: 3480046
[No Abstract] [Full Text] [Related]
19. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
